318 results
8-K
APTO
Aptose Biosciences Inc
5 Apr 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:05pm
be no assurance that the Compliance Plan will be accepted by Nasdaq. If the Compliance Plan is accepted by Nasdaq, the Company will be granted an extension
8-K
2sg4051w
1 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
8-K
EX-1.1
e7oya9wt
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
8-K
EX-10.1
xi5o5ig3zf0
29 Jan 24
Entry into a Material Definitive Agreement
9:44pm
424B4
uqqx 4bby8
26 Jan 24
Prospectus supplement with pricing info
5:30pm